chemotherapy

Open Access
Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity
Shumeng Lin, Liuliu Yuan, Xiao Chen, Shiyin Chen, Mengling Wei, Bingjie Hao, Tiansheng Zheng and Lihong Fan

Cancer Biology & Medicine June 2025, 22 (6) 648-671; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0596
Open Access
Research progress in tumor angiogenesis and drug resistance in breast cancer
Jiancheng Mou, Chenhong Li, Qinghui Zheng, Xuli Meng and Hongchao Tang

Cancer Biology & Medicine July 2024, 21 (7) 571-585; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0515
You have access
Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu

Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474
You have access
Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren

Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
You have access
Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance
Rui Li, Zhimin Chen, Zhifei Dai and Yingjie Yu

Cancer Biology & Medicine May 2021, 18 (2) 388-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0328
You have access
Adaptive response of resistant cancer cells to chemotherapy
Yi-Jye Chern and Isabella T. Tai

Cancer Biology & Medicine November 2020, 17 (4) 842-863; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0005
You have access
Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study
Liqiang Wei, Lei Yang, Jin Ye, Jia Cong, Xin Li, Na Yao, Jing Yang, Xueying Cui, Jing Ding, Yiping Wu and Jingwen Wang

Cancer Biology & Medicine August 2020, 17 (3) 795-804; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0160
You have access
Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications
Xiaofei Zhu, Di Chen, Yangsen Cao, Xianzhi Zhao, Xiaoping Ju, Yuxin Shen, Fei Cao, Shuiwang Qing, Fang Fang, Zhen Jia and Huojun Zhang

Cancer Biology & Medicine May 2020, 17 (2) 492-500; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0101
You have access
The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
Francisco Quiñonero, Cristina Mesas, Kevin Doello, Laura Cabeza, Gloria Perazzoli, Cristina Jimenez-Luna, Ana Rosa Rama, Consolación Melguizo and Jose Prados

Cancer Biology & Medicine November 2019, 16 (4) 688-699; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0252
You have access
G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future
Angel Mauricio Castro-Gamero, Julia Alejandra Pezuk, María Sol Brassesco and Luiz Gonzaga Tone

Cancer Biology & Medicine November 2018, 15 (4) 354-374; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0030

Main menu

User menu

Search

chemotherapy

Pages

Navigate

More Information

For Authors

Journal Services